76 related articles for article (PubMed ID: 15214331)
1. Colorectal cancer market.
Smith RE; Renaud RC; Hoffman E
Nat Rev Drug Discov; 2004 Jun; 3(6):471-2. PubMed ID: 15214331
[No Abstract] [Full Text] [Related]
2. Oxaliplatin.
Graham J; Mushin M; Kirkpatrick P
Nat Rev Drug Discov; 2004 Jan; 3(1):11-2. PubMed ID: 14756144
[No Abstract] [Full Text] [Related]
3. Colorectal cancer drugs market.
Cassidy S; Syed BA
Nat Rev Drug Discov; 2017 Aug; 16(8):525-526. PubMed ID: 28529321
[No Abstract] [Full Text] [Related]
4. Dose rounding of chemotherapy in colorectal cancer: an analysis of clinician attitudes and the potential impact on treatment costs.
Field K; Zelenko A; Kosmider S; Court K; Ng LL; Hibbert M; Gibbs P
Asia Pac J Clin Oncol; 2010 Sep; 6(3):203-9. PubMed ID: 20887502
[TBL] [Abstract][Full Text] [Related]
5. A critical review of the full economic evaluations of pharmacological treatments for colorectal cancer.
Garattini L; Compadri PD; Koleva D; Pasina L; Nobili A
J Med Econ; 2008; 11(1):177-97. PubMed ID: 19450119
[TBL] [Abstract][Full Text] [Related]
6. [Quality of life in patients with colorectal cancer].
Conroy T; Rauch P; Guillemin F
Gastroenterol Clin Biol; 1999 Apr; 23(4):489-501. PubMed ID: 10416113
[No Abstract] [Full Text] [Related]
7. [When are new antineoplastic drugs needed?].
Elomaa I
Duodecim; 2000; 116(6):573-5. PubMed ID: 11787109
[No Abstract] [Full Text] [Related]
8. Does reimbursement influence chemotherapy treatment for cancer patients?
Jacobson M; O'Malley AJ; Earle CC; Pakes J; Gaccione P; Newhouse JP
Health Aff (Millwood); 2006; 25(2):437-43. PubMed ID: 16522584
[TBL] [Abstract][Full Text] [Related]
9. [Costs, disease management and DRG].
Barni S; Mandalà M; Gambera M
Tumori; 2001; 87(1 Suppl 1):S59. PubMed ID: 11300029
[No Abstract] [Full Text] [Related]
10. Medicare's coverage of colorectal cancer drugs: a case study in evidence development and policy.
Carino T; Williams RD; Colbert AM; Bridger P
Health Aff (Millwood); 2006; 25(5):1231-9. PubMed ID: 16966718
[TBL] [Abstract][Full Text] [Related]
11. [[How to finance chemotherapy with new cancer drugs?].
Livartowski A; Beuzeboc P; Le Vu B; Courbard M; Pierga JY; Extra JM; Scholl S; Pouillart P
Bull Cancer; 2000 Oct; 87(10):745-54. PubMed ID: 11084538
[TBL] [Abstract][Full Text] [Related]
12. The value of new chemotherapeutic agents for metastatic colorectal cancer.
Howard DH; Kauh J; Lipscomb J
Arch Intern Med; 2010 Mar; 170(6):537-42. PubMed ID: 20233802
[TBL] [Abstract][Full Text] [Related]
13. Therapy for colorectal cancer.
Etzioni S; Rosenfeld K
N Engl J Med; 2005 Apr; 352(17):1820-2; author reply 1820-2. PubMed ID: 15864824
[No Abstract] [Full Text] [Related]
14. Introduction: Advances in treatment of metastatic colorectal cancer.
Folprecht G
Cancer Treat Rev; 2008; 34 Suppl 2():S1-2. PubMed ID: 19101402
[No Abstract] [Full Text] [Related]
15. Colorectal cancer chemotherapy.
Woodcock TM
J Ky Med Assoc; 2009 Mar; 107(3):93-4. PubMed ID: 19361080
[No Abstract] [Full Text] [Related]
16. Colorectal cancer.
Zalcberg JR
Med J Aust; 1999 Mar; 170(6):283; author reply 284. PubMed ID: 10212653
[No Abstract] [Full Text] [Related]
17. Progresses in the medical treatment of advanced colorectal cancer.
Sultan-Amar V; Fabre-Guillevin E; Piedbois P
Rocz Akad Med Bialymst; 2005; 50():97-100. PubMed ID: 16358946
[TBL] [Abstract][Full Text] [Related]
18. [Pharmacogenetics and tumor sensitivity of antineoplastic agents. Application to colorectal cancer].
Milano G
Rev Prat; 2008 May; 58(10):1056-9. PubMed ID: 18652401
[TBL] [Abstract][Full Text] [Related]
19. [Tailored treatment to patients with metastatic colorectal cancer].
Pfeiffer P; Qvortrup C; Hansen TP
Ugeskr Laeger; 2009 Mar; 171(13):1098. PubMed ID: 19321093
[No Abstract] [Full Text] [Related]
20. Oxaliplatin in colorectal cancer: an overview.
Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
